Table III.
Author, year | Outcomes assessed | Conclusions | (Refs.) |
---|---|---|---|
Rooyackers | i) Maximal cycle ergometry-4 lpm O2 and room air | Pulmonary rehabilitation improved exercise | (11) |
et al, 1997 | ii) Constant power cycle ergometry-30% O2 and | performance and quality of life in both | |
room air | groups. O2 supplementation during the | ||
iii) 6MWT-4 lpm O2 and room air | training did not add to the effects of training | ||
iv) Stair climb-up 4, plateau, down 3 | on room air. | ||
v) Weight lift-lift between racks | |||
vi) Chronic respiratory Disease Questionnaire | |||
vii) PFT-Spirometry and transfer coefficient for | |||
carbon monoxide | |||
Garrod | i) Shuttle walk test | Supplemental O2 during training does little to | (12) |
et al, 2000 | ii) Chronic respiratory Disease Questionnaire | enhance exercise tolerance although there is a | |
iii) Hospital Anxiety and Depression Scale | small benefit in terms of dyspnea. Patients with | ||
iv) London Chest Activity of Daily Living Scale | severe disabling dyspnea may find symptomatic | ||
relief with supplemental oxygen. | |||
Wadell | i) 6MWT on 5 lpm O2 and 5 lpm compressed | Supplemental O2 did not further improve the | (13) |
et al, 2001 | air (random order) with a 1 h rest in between | training effect, compared with training with air, | |
ii) Arterial blood gas analysis | in patients with chronic obstructive pulmonary disease. | ||
Emtner | i) Maximal cycle ergometry-30% O2 and | Supplemental O2 provided during high-intensity | (15) |
et al, 2003 | compressed air | training yields higher training intensity and | |
ii) Constant power cycle ergometry-30% O2 | evidence of gains in exercise tolerance in | ||
and compressed air | laboratory testing. | ||
iii) Chronic respiratory disease questionnaire | |||
iv) SF-36 | |||
v) PFT-spirometry and lung volume | |||
vi) Arterial blood gas analysis | |||
Scorsone | i) PFT | O2 supplementation does not contribute to | (24) |
et al, 2010 | ii) Maximal cycle ergometry | improved exercise performance in patients with | |
iii) Constant power cycle ergometry | moderate to severe COPD. | ||
iv) Arterial blood gas analysis | |||
Spielmanns | i) 6MWT-room air | O2 supplemental oxygen during the training | (26) |
et al, 2014 | ii) Maximal cycle ergometry-room air | program had no additional benefits in improving | |
iii) SF-36 | quality of life and exercise capacity in subjects | ||
with moderate-to-severe COPD. | |||
Alison | i) Endurance shuttle walk test | Both O2 and Air groups significantly improved | (25) |
et al, 2019 | ii) Incremental shuttle walk test | exercise capacity and health related quality of life | |
iii) Chronic Respiratory Disease Questionnaire | with no greater benefit from training with | ||
iv) Dyspnoea-12 Questionnaire | supplemental O2 than with medical air. |
lpm, liter per minute; 6MWT, 6-min walking distance test; SF-36, Medical Outcomes Survey Short Form 36 questionnaire; PFT, Pulmonary Function Test.